Rapport Therapeutics, Inc. · NASDAQ:RAPP

Capital International Investors reported a 6.10% stake in Rapport Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 12, 2026

Capital International Investors reported a 6.10% stake in Rapport Therapeutics, Inc., 2,921,958 shares, as a passive investor on Jun 30, 2026. Filed Aug 12, 2026 (Schedule 13G/A).

Stake
6.10%
Shares
2,921,958
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
Capital International Investors6.10%2,921,958

Source

View original at SEC

Related